Sfoglia per AUTORE
PELLA P
Collezione AOU Novara

  

Items : 2

Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838-e841. doi: 10.1111/jdv.18314. Epub 2022 Jun 22.

2022
ASL Alessandria
ASL Vercelli
ASL Asti
ASL Torino 4
ASL Biella
AO Alessandria
AOU Novara

Ribero S; Dapavo P; Quaglino P; Tiberio R; Graziola F; Giura MT; Mocci L; Merlo G; Pella P; Rossotto G; Peila R; Addese C; Baggini G; Pertusi G; Aragone MG; Solaroli C; Licciardello M; Cariti C; Macagno N; Boskovic S; Leporati C; Passerini SG; Susca S; Verrone A; Ortoncelli M; Stroppiana E; Mastorino L; Castelli F;

Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2021 Mar;35(3):693-700. doi: 10.1111/jdv.16931. Epub 2020 Oct 13.

2021
ASL Biella
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Cannavò SP; Esposito M; Dapavo P; Pellegrini C; Nacca M; Gattoni M; Bardazzi F; Cusano F; Pella P; Loconsole F; Lo Schiavo A; Argenziano G; Gisondi P; Dastoli S; Offidani AM; Tiberio R; Rossi M; Parodi A; Fargnoli MC; Costanzo A;